Market Cap (In SEK)
17.05 Million
Revenue (In SEK)
-
Net Income (In SEK)
-23.73 Million
Avg. Volume
1.23 Million
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.19-1.05
- PE
- -
- EPS
- -
- Beta Value
- 0.23
- ISIN
- SE0013513652
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Andreas Gerward M.Sc.
- Employee Count
- -
- Website
- https://www.staybletherapeutics.se
- Ipo Date
- 2020-03-09
- Details
- Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
More Stocks
-
KWG
-
AV
-
NURI
-
PPL
-
GET
-
BLXBoralex Inc.
BLX
-
9890ZX Inc
9890
-
AMJLANDAMJ Land Holdings Limited
AMJLAND